We are live on
!
Find out more
FP
Foundry Partners Portfolio holdings
AUM
$1.89B
1-Year Est. Return
9.84%
This Fund
S&P 500
This Quarter
Est. Return
+0.53%
1 Year Est. Return
+9.84%
3 Year Est. Return
+44.42%
5 Year Est. Return
+233.04%
10 Year Est. Return
+297.72%
AUM
$1.99B
AUM Growth
-$31M
(-1.5%)
Cap. Flow
+$2.59M
Cap. Flow
% of AUM
0.13%
Top 10 Holdings %
Top 10 Hldgs %
17.9%
Holding
309
New
25
Increased
122
Reduced
118
Closed
40
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$22.7M |
| 2 |
Pfizer
PFE
|
+$21.5M |
| 3 |
Quest Diagnostics
DGX
|
+$16.8M |
| 4 |
The Mosaic Company
MOS
|
+$15.1M |
| 5 |
Hancock Whitney
HWC
|
+$13.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$16M |
| 2 |
Merck
MRK
|
+$15.9M |
| 3 |
LyondellBasell Industries
LYB
|
+$15.7M |
| 4 |
Phillips 66
PSX
|
+$13.8M |
| 5 |
Johnson & Johnson
JNJ
|
+$11.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 24.91% |
| 2 | Industrials | 16.38% |
| 3 | Technology | 11.11% |
| 4 | Healthcare | 10.84% |
| 5 | Consumer Discretionary | 6.97% |
Similar funds
ST
UH
PAME
TW
AP
MBA
SSB
CC
Foundry Partners's Q4 2024 Portfolio in Review
As of Q4 2024, Foundry Partners held 309 positions worth $1.99B, down 1.5% from $2.02B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Foundry Partners's Q4 2024 filing shows 25 new, 122 increased, 118 reduced and 40 closed positions. Its largest new stake was Bristol-Myers Squibb: 406,683 shares worth $23M. The largest sale was GSK, an estimated $16M.
By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 21% a quarter earlier, followed by Industrials and Technology.
- Foundry Partners's largest Q4 2024 buy was Bristol-Myers Squibb: 406,683 shares worth $23M.
- Foundry Partners added most to Walt Disney in Q4 2024, an estimated $8.81M increase.
- Foundry Partners's biggest Q4 2024 reduction was Johnson & Johnson, cutting an estimated $11.1M.
- Foundry Partners fully exited GSK in Q4 2024, selling an estimated $16M.
- Foundry Partners's ten largest holdings make up 18% of its $1.99B portfolio in Q4 2024.
- Foundry Partners opened 25 new positions and closed 40 in Q4 2024.
- Foundry Partners's portfolio value fell 1.5% quarter-over-quarter to $1.99B.
Based on Foundry Partners's 13F filing for Q4 2024, filed 12 Feb 2025.